Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies
2012
DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson’s disease
2014
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
Genomewide Association Studies and Human Disease
2009
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
2009
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Alzheimer's disease
2011 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease
2008
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 Standout
Tau in physiology and pathology
2015 Standout
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Principles of early drug discovery
2010 Standout
Antisense Reduction of Tau in Adult Mice Protects against Seizures
2013
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
2008
Frontotemporal Dementia
2017
An Inflection Point in Gene Discovery Efforts for Neurodegenerative Diseases
2013
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
2016
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
2009
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
2012
The Pathobiology of Vascular Dementia
2013 Standout
The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults
2016
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies
2012
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
2009 Standout
Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
2007
Tau alternative splicing in familial and sporadic tauopathies
2012
Alzheimer's disease
2017 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Regulation of astrocyte inflammatory responses by the Parkinson's disease‐associated gene DJ–1
2009
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
2008
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Liquid-Liquid Phase Separation in Biology
2014 Standout
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
The MoCA
2010 Standout
Parkinson's Disease: Genetics and Pathogenesis
2011
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Works of Mona Kaleem being referenced
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts
2006
Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization
2004